This is a prospective registry study to surveil early liver injuries caused by Yangxue Shengfa Capsule (YXSF Capsule) through a non-intervention observational way. And attempt to establish a predictive model to screen susceptibilities to YXSF Capsule.
The primary objectives of this study include: (i) The detection of patients with serum liver biochemistry abnormalities less than 8 weeks after intake of YXSF Capsule; (ii) The record of overall individuals with demographics, underlying diseases, physical status, medication information, clinical laboratory index, and so on; (iii) The specimen collection of surveiled individuals. (iv) The attempt to establish a predictive model to screen susceptibilities to YXSF Capsule.
Study Type
OBSERVATIONAL
Enrollment
1,000
302 Military Hospital
Beijing, Beijing Municipality, China
Number of patients with serum liver biochemistry abnormalities less than 8 weeks after intake of YXSF Capsule.
The detection of patients with serum liver biochemistry abnormalities less than 8 weeks after intake of YXSF Capsule.
Time frame: participants will be followed duration intake of YXSF Capsule, an expected average of 8 weeks
Clinical features of early liver injuries caused by YXSF Capsule assessed by serum parameters of liver function.
Clinical features of early liver injuries caused by YXSF Capsule assessed by serum parameters of liver function, such as liver biochemistry.
Time frame: participants will be followed duration intake of YXSF Capsule, an expected average of 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.